Unfortunately, measurements on mitochondrial activity comparing ER-positive and ER-negative clinical specimens are to our knowledge not reported in the literature, and thus the effect of differences in ESR1 levels on mitochondrial activity in primary breast tumors remains currently unknown. This evidence concerns the gene ESR1 and breast neoplasm.